Publication: Synthesis, biological evaluation and in silico study of bis-thiourea derivatives as anticancer, antimalarial and antimicrobial agents
1
0
Issued Date
2017
Resource Type
File Type
application/pdf
ISSN
10542523
Other identifier(s)
2-s2.0-85028960760
Rights Holder(s)
Scopus
Bibliographic Citation
Medicinal Chemistry Research. Vol 26, No.12 (2017), p.3136-3148
Suggested Citation
Pingaew R., Sinthupoom N., Mandi P., Prachayasittikul V., Cherdtrakulkiat R., Prachayasittikul S., Ruchirawat S., Prachayasittikul V. Synthesis, biological evaluation and in silico study of bis-thiourea derivatives as anticancer, antimalarial and antimicrobial agents. Medicinal Chemistry Research. Vol 26, No.12 (2017), p.3136-3148. doi:10.1007/s00044-017-2008-5 Retrieved from: https://hdl.handle.net/20.500.14740/3993
Abstract
Two sets of bis-thioureas including a para series (8–14) and a meta series (4, 5, 15–19), were synthesized and evaluated for their anticancer, antimalarial and antimicrobial activities. Most of the synthesized bis-thioureas, except for analogs 8–11, displayed cytotoxicity against MOLT-3 cell line (IC50 = 1.55–32.32 µM). Derivatives 5, 14, 18 and 19 showed a broad spectrum of anticancer activity. Analogs (4, 5, 8, 13, 14, 18 and 19) exhibited higher inhibitory efficacy in HepG2 cells than the control drug, etoposide. Significantly, bis-trifluoromethyl analog 19 was the promising potent cytotoxic agent (IC50 = 1.50–18.82 µM) with the best safety index (1.64–20.60). Antimalarial activity results showed that trifluoromethyl derivative 18 was the most potent compound (IC50 = 1.92 µM, selective index = 6.86). Antimicrobial activity revealed that bis-thioureas 12, 18 and 19 exhibited selective activity against Gram-positive bacteria and fungi. Promisingly, the bis-trifluoromethyl derivative 19 was the most potent compound in the series and displayed higher potency, against most of the Gram-positive bacteria and fungi, than that of ampicillin, the reference drug. Among the tested strains of microorganisms, compound 19 inhibited the growth of Staphylococcus epidermidis ATCC 12228 and Micrococcus luteus ATCC 10240 with the lowest MIC of 1.47 µM. The findings demonstrated that trifluoromethyl group plays a crucial role in their biological activities. Furthermore, the molecular docking was performed to reveal possible binding modes of the compounds against target proteins. © 2017, Springer Science+Business Media, LLC.
Subject(s)
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 bromophenyl)thiourea]
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 methoxyphenyl)thiourea]
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 trifluoromethylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (3,5 ditrifluoromethylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 bromophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 chlorophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 methoxyphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 methylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 nitrophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 trifluoromethylphenyl)thiourea]
Ampicillin
Antiinfective agent
Antimalarial agent
Antineoplastic agent
Colchicine
Cytotoxic agent
DNA topoisomerase IV
Doxorubicin
Etoposide
Novobiocin
Thiourea derivative
Tubulin
Unclassified drug
Achromobacter xylosoxidans
Agar dilution
Animal cell
Antimalarial activity
Antimicrobial activity
Antineoplastic activity
Article
Bacillus cereus
Bacillus subtilis
Binding site
Carbon nuclear magnetic resonance
Computer model
Controlled study
Cytotoxicity
Drug potency
Drug safety
Drug screening
Drug structure
Drug synthesis
Hep-G2 cell line
Human
Human cell
Hydrogen bond
IC50
Infrared spectroscopy
Listeria monocytogenes
Mass spectrometry
Micrococcus luteus
Minimum inhibitory concentration
Molecular docking
MOLT-3 cell line
Nonhuman
Plasmodium falciparum
Plesiomonas shigelloides
Proton nuclear magnetic resonance
Saccharomyces cerevisiae
Selectivity index
Shigella dysenteriae
Staphylococcus epidermidis
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 methoxyphenyl)thiourea]
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 trifluoromethylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (3,5 ditrifluoromethylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 bromophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 chlorophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 methoxyphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 methylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 nitrophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 trifluoromethylphenyl)thiourea]
Ampicillin
Antiinfective agent
Antimalarial agent
Antineoplastic agent
Colchicine
Cytotoxic agent
DNA topoisomerase IV
Doxorubicin
Etoposide
Novobiocin
Thiourea derivative
Tubulin
Unclassified drug
Achromobacter xylosoxidans
Agar dilution
Animal cell
Antimalarial activity
Antimicrobial activity
Antineoplastic activity
Article
Bacillus cereus
Bacillus subtilis
Binding site
Carbon nuclear magnetic resonance
Computer model
Controlled study
Cytotoxicity
Drug potency
Drug safety
Drug screening
Drug structure
Drug synthesis
Hep-G2 cell line
Human
Human cell
Hydrogen bond
IC50
Infrared spectroscopy
Listeria monocytogenes
Mass spectrometry
Micrococcus luteus
Minimum inhibitory concentration
Molecular docking
MOLT-3 cell line
Nonhuman
Plasmodium falciparum
Plesiomonas shigelloides
Proton nuclear magnetic resonance
Saccharomyces cerevisiae
Selectivity index
Shigella dysenteriae
Staphylococcus epidermidis